Hematology/Oncology

Top Story

VIDEO: Multivitamin use before breast cancer diagnosis may reduce peripheral neuropathy risk

April 28, 2016

NEW ORLEANS — Multivitamin supplement use appeared associated with a reduced risk for chemotherapy-induced peripheral neuropathy among patients with breast cancer, according to study results Gary Zirpoli, PhD, research fellow at Roswell Park Cancer Institute, presented at the American Association for Cancer Research Annual Meeting.

In the Journals

Monthly cost of oral cancer drugs rises steadily over time

April 28, 2016
The cost of oral cancer drugs in their first year on the market has increased significantly since the year 2000, according to a research letter published in JAMA
In the Journals

Cancer diagnosis increases risk for mental disorders, psychiatric medication use

April 28, 2016
Patients diagnosed with cancer faced an increased risk for common mental disorders — such as depression, anxiety and stress reaction/adjustment disorder —…
Video

VIDEO: Tumor-infiltrating lymphocytes may predict response to immunotherapy in breast cancer

April 28, 2016
Determining which tumor-infiltrating lymphocytes may predict response to immunotherapy among patients with breast cancer, and identifying biomarkers that indicate cell…
FDA News

FDA grants fast track designation to ADXS-HER2 for osteosarcoma

April 28, 2016
The FDA granted fast track designation to ADXS-HER2 for treatment of newly diagnosed, nonmetastatic, surgically resectable osteosarcoma, according to a press release…
More News Headlines »
CME Video

World Lung Updates: Immunotherapy in NSCLC

This activity is supported by an educational grant from Genentech, Inc and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for…
More »
Video
Meeting News Coverage

VIDEO: CAR-T cell therapy may target EGFR variant III in glioblastoma

April 26, 2016
More »
Featured
At Issue: Multiple Myeloma Resource Center

At Issue: Multiple Myeloma Resource Center

CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan